Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 244

1.

Wilms' tumor protein Wt1 is an activator of the anti-Müllerian hormone receptor gene Amhr2.

Klattig J, Sierig R, Kruspe D, Besenbeck B, Englert C.

Mol Cell Biol. 2007 Jun;27(12):4355-64. Epub 2007 Apr 9.

2.
3.

A GATA4/WT1 cooperation regulates transcription of genes required for mammalian sex determination and differentiation.

Miyamoto Y, Taniguchi H, Hamel F, Silversides DW, Viger RS.

BMC Mol Biol. 2008 Apr 29;9:44. doi: 10.1186/1471-2199-9-44.

4.

Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.

Borel F, Barilla KC, Hamilton TB, Iskandar M, Romaniuk PJ.

Biochemistry. 1996 Sep 17;35(37):12070-6.

PMID:
8810912
5.

The human sex-determining gene SRY is a direct target of WT1.

Hossain A, Saunders GF.

J Biol Chem. 2001 May 18;276(20):16817-23. Epub 2001 Feb 20.

6.

Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome.

Pelletier J, Bruening W, Kashtan CE, Mauer SM, Manivel JC, Striegel JE, Houghton DC, Junien C, Habib R, Fouser L, et al.

Cell. 1991 Oct 18;67(2):437-47.

PMID:
1655284
7.

Identification, expression, and regulation of anti-Müllerian hormone type-II receptor in the embryonic chicken gonad.

Cutting AD, Ayers K, Davidson N, Oshlack A, Doran T, Sinclair AH, Tizard M, Smith CA.

Biol Reprod. 2014 May;90(5):106. doi: 10.1095/biolreprod.113.116491. Epub 2014 Mar 12.

PMID:
24621923
8.

CTNNB1 mutations and overexpression of Wnt/beta-catenin target genes in WT1-mutant Wilms' tumors.

Li CM, Kim CE, Margolin AA, Guo M, Zhu J, Mason JM, Hensle TW, Murty VV, Grundy PE, Fearon ER, D'Agati V, Licht JD, Tycko B.

Am J Pathol. 2004 Dec;165(6):1943-53.

9.

Wnt-4 regulation by the Wilms' tumour suppressor gene, WT1.

Sim EU, Smith A, Szilagi E, Rae F, Ioannou P, Lindsay MH, Little MH.

Oncogene. 2002 May 2;21(19):2948-60.

10.

Role of Wilms tumor 1 (WT1) in the transcriptional regulation of the Mullerian-inhibiting substance promoter.

Hossain A, Saunders GF.

Biol Reprod. 2003 Dec;69(6):1808-14. Epub 2003 Jul 9.

PMID:
12855602
11.

Wilms' tumor 1 and Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression.

Nachtigal MW, Hirokawa Y, Enyeart-VanHouten DL, Flanagan JN, Hammer GD, Ingraham HA.

Cell. 1998 May 1;93(3):445-54.

12.

The role of Wilms' tumor genes.

Hirose M.

J Med Invest. 1999 Aug;46(3-4):130-40. Review.

PMID:
10687307
13.

Functional characterization of WT1 binding sites within the human vitamin D receptor gene promoter.

Lee TH, Pelletier J.

Physiol Genomics. 2001 Dec 21;7(2):187-200.

PMID:
11773605
14.

New insights into the function of the Wilms tumor suppressor gene WT1 in podocytes.

Morrison AA, Viney RL, Saleem MA, Ladomery MR.

Am J Physiol Renal Physiol. 2008 Jul;295(1):F12-7. doi: 10.1152/ajprenal.00597.2007. Epub 2008 Apr 2. Review.

PMID:
18385267
15.
16.

Expression of inhibin-alpha is regulated synergistically by Wilms' tumor gene 1 (Wt1) and steroidogenic factor-1 (Sf1) in sertoli cells.

Ji SY, Hao JX, Li L, Zhang J, Zheng QS, Li XX, Wang XN, Han CS, Gao F, Liu YX.

PLoS One. 2013;8(1):e53140. doi: 10.1371/journal.pone.0053140. Epub 2013 Jan 11.

17.

The Wilms' tumor suppressor Wt1 activates transcription of the erythropoietin receptor in hematopoietic progenitor cells.

Kirschner KM, Hagen P, Hussels CS, Ballmaier M, Scholz H, Dame C.

FASEB J. 2008 Aug;22(8):2690-701. doi: 10.1096/fj.07-097576. Epub 2008 Apr 18.

PMID:
18424770
18.

Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.

Zaia A, Fraizer GC, Piantanelli L, Saunders GF.

Anticancer Res. 2001 Jan-Feb;21(1A):1-10.

PMID:
11299720
19.

Integration of Cistromic and Transcriptomic Analyses Identifies Nphs2, Mafb, and Magi2 as Wilms' Tumor 1 Target Genes in Podocyte Differentiation and Maintenance.

Dong L, Pietsch S, Tan Z, Perner B, Sierig R, Kruspe D, Groth M, Witzgall R, Gröne HJ, Platzer M, Englert C.

J Am Soc Nephrol. 2015 Sep;26(9):2118-28. doi: 10.1681/ASN.2014080819. Epub 2015 Jan 2.

20.

Murine Denys-Drash syndrome: evidence of podocyte de-differentiation and systemic mediation of glomerulosclerosis.

Patek CE, Fleming S, Miles CG, Bellamy CO, Ladomery M, Spraggon L, Mullins J, Hastie ND, Hooper ML.

Hum Mol Genet. 2003 Sep 15;12(18):2379-94. Epub 2003 Jul 22.

PMID:
12915483

Supplemental Content

Support Center